Amicus sets $315,000 price for new Fabry disease treatment By: Reuters: Company News August 13, 2018 at 08:28 AM EDT Amicus Therapeutics priced its new Fabry disease treatment at an average $315,000 per year in the United States, the company said on Monday. Read More >> Related Stocks: Amicus Therapeutics Banco Santander ADR
